Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices 43875 

HISTORY: 

The history of the Board’s various 

systems can be located at: https://

www.federalreserve.gov/system-ofrecords-notices.htm by clicking on the 

Federal Register Notice associated with 

the SORN for each system. In order that 

the Board’s General Routine Uses will 

be contained in a single notice readily 

accessible by the public, the Board is 

taking the opportunity to republish the 

General Routine Uses previously 

published on May 6, 2008 (73 FR 24985) 

which were not revised under this 

notice. 

Board of Governors of the Federal Reserve 

System, August 23, 2018. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2018–18627 Filed 8–27–18; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–1102] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Information 

Collection for Tuberculosis Data from 

Panel Physicians to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on May 29, 

2018 to obtain comments from the 

public and affected agencies. CDC 

received three comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

Information Collection for 

Tuberculosis Data from Panel 

Physicians—Revision—National Center 

for Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention’s (CDC), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Division of Global 

Migration and Quarantine (DGMQ), 

Immigrant, Refugee, and Migrant Health 

Branch (IRMH), requests approval for a 

revision of an existing information 

collection. This project pertains to 

collecting annual reports on certain 

tuberculosis data from U.S. panel 

physicians. 

The respondents are panel physicians. 

More than 760 panel physicians from 

336 panel sites perform overseas predeparture medical examinations in 

accordance with requirements, referred 

to as technical instructions, provided by 

DGMQs Quality Assessment Program 

(QAP). The role of QAP is to assist and 

guide panel physicians in the 

implementation of the Technical 

Instructions; evaluate the quality of the 

overseas medical examination for U.S.- 

bound immigrants and refugees; assess 

potential panel physician sites; and 

provide recommendations to the U.S. 

Department of State in matters of 

immigrant medical screening. 

To achieve DGMQ’s mission, the 

Immigrant, Refugee and Migrant Health 

branch (IRMH) works with domestic 

and international programs to improve 

the health of U.S.-bound immigrants 

and refugees to protect the U.S. public 

by preventing the importation of 

infectious disease. These goals are 

accomplished through IRMH’s oversight 

of medical exams required for all U.S.— 

bound immigrants and refugees who 

seek permanent residence in the U.S. 

IRMH is responsible for assisting and 

training the international panel 

physicians with the implementation of 

medical exam Technical Instructions 

(TI). Technical Instructions are detailed 

requirements and national policies 

regarding the medical screening and 

treatment of all U.S.-bound immigrants 

and refugees. 

Screening for tuberculosis (TB) is a 

particularly important component of the 

immigration medical exam and allows 

panel physicians to diagnose active TB 

disease prior to arrival in the United 

States. As part of the Technical 

Instructions requirements, panel 

physicians perform chest x-rays and 

laboratory tests that aid in the 

identification of tuberculosis infection 

(Class B1 applicants) and diagnosis of 

active tuberculosis disease (Class A, 

inadmissible applicants). CDC uses 

these classifications to report new 

immigrant and refugee arrivals with a 

higher risk of developing TB disease to 

U.S. state and local health departments 

for further follow-up. Some information 

that panel physicians collect as part of 

the medical exam is not reported on the 

standard Department of State forms (DSforms), thereby preventing CDC from 

evaluating TB trends in globally mobile 

populations and monitoring program 

effectiveness. 

Currently, CDC is requesting this data 

be sent by panel physicians once per 

year. The consequences of reducing this 

frequency would be the loss of 

monitoring program impact and TB 

burdens in mobile populations and 

immigrants and refugees coming to the 

United States on an annual basis. 

Estimated annual burden is being 

reduced by 1,640 hours per year. The 

number of respondents is being reduced 

by 17. Reductions are due to revised 

estimates on burden time per response, 

and the removal of four variables from 

the data collection form and improved 

IT capacity at most panel sites. The total 

hours requested is 1,008. There is no 

cost to the respondents other than their 

time. 


daltland on DSKBBV9HB2PROD with NOTICES
43876 Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

International panel physicians ........................ TB Indicators Excel Spreadsheet .................. 336 1 3 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–18588 Filed 8–27–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0600; Docket No. CDC–CDC– 

2008–0079] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled CDC Model Performance 

Evaluation Program (MPEP) for 

Mycobacterium tuberculosis 

Susceptibility Testing information 

collection. CDC is requesting a threeyear approval for revision to the 

previously approved project used to 

monitor and evaluate performances and 

practices among national laboratories M. 

tuberculosis susceptibility testing. 

DATES: CDC must receive written 

comments on or before October 29, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2008– 

00791 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffery M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

CDC Model Performance Evaluation 

Program (MPEP) for Mycobacterium 

tuberculosis Susceptibility testing (OMB 

#0920–0600, expiration 3/31/2019)— 

Revision—National Center for HIV/ 

AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The CDC is requesting a revision to 

the approved information collection, 

CDC Model Performance for 

Mycobacterium tuberculosis Drug 

Susceptibility Testing (OMB Control 

Number 0920–0600). Clearance is 

requested for a period of three years. 

Revision of this information collection 

will not require changes in the scope of 

the study. This revision includes (a) 

modification of the Participant Biosafety 

Compliance Letter of Agreement; (b) 

modification of the Instructions to 

Participants Letter; (c) modification of 

the MPEP Mycobacterium Results 

Worksheet; (d) Request for approval of 

a MPEP Mycobacterium tuberculosis 

Minimum Inhibitory Concentration 

(MIC) Results Form for laboratories that 

perform Sensititre Drug Susceptibility 

Testing (DST) to record MIC results; and 

(e) reduction in request for burden 

hours. 

While the overall number of cases of 

TB in the U.S. has decreased, rates still 

remain high among foreign-born 

persons, prisoners, homeless 

populations, and individuals infected 

with HIV in major metropolitan areas. 

To reach the goal of eliminating TB, the 

Model Performance Evaluation Program 

for Mycobacterium tuberculosis 

Susceptibility Testing is used to monitor 

and evaluate performance and practices 

among national laboratories performing 

M. tuberculosis susceptibility testing. 

Participation in this program is one way 


daltland on DSKBBV9HB2PROD with NOTICES